Platelet-induced inhibition of tumor cell growth

Thrombosis Research

Volumn 123, Issue 2, 2008, Pages 324-330

  Wang, Yiqiang ^a,b   Zhang, Hongbo ^a,b  

^a SHANDONG EYE INSTITUTE   (China)

^b QINGDAO UNIVERSITY   (China)

Author keywords

Cell cycle; Platelet; Proliferation; Tumor

Indexed keywords

DNA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CULTURE; CELL CYCLE; CELL CYCLE ARREST; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; FLOW CYTOMETRY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION; TUMOR GROWTH;

ANIMALS; APOPTOSIS; BIOLOGICAL PROCESSES; BLOOD PLATELETS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COCULTURE TECHNIQUES; DNA REPLICATION; LYMPHOMA; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASMS; PROSTATIC NEOPLASMS;

EID: 55549104015     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.06.021     Document Type: Article

References (26)

1. Gupta G.P., and Massague J. Platelets and metastasis revisited: a novel fatty link. J Clin Invest 114 (2004) 1691-1693
2. Gasic G.J., Gasic T.B., and Stewart C.C. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A 61 (1968) 46-52
3. Nierodzik M.L., Klepfish A., and Karpatkin S. Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo. Thromb Haemost 74 (1995) 282-290
4. Jurasz P., Alonso-Escolano D., and Radomski M.W. Platelet-cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation. Br J Pharmacol 143 (2004) 819-826
5. Nieswandt B., Hafner M., Echtenacher B., and Mannel D.N. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 59 (1999) 1295-1300
6. Rickles F.R., and Falanga A. Molecular basis for the relationship between thrombosis and cancer. Thromb Res 102 (2001) V215-224
7. Eldor A., Bar-Ner M., Yahalom J., Fuks Z., and Vlodavsky I. Role of heparanase in platelet and tumor cell interactions with the subendothelial extracellular matrix. Semin Thromb Hemost 13 (1987) 475-488
8. Morimoto K., Satoh-Yamaguchi K., Hamaguchi A., Inoue Y., Takeuchi M., Okada M., et al. Interaction of cancer cells with platelets mediated by Necl-5/poliovirus receptor enhances cancer cell metastasis to the lungs. Oncogene 27 (2008) 264-273
9. Niers T.M., Klerk C.P., DiNisio M., Van Noorden C.J., Buller H.R., Reitsma P.H., et al. Mechanisms of heparin induced anti-cancer activity in experimental cancer models. Crit Rev Oncol Hematol 61 (2007) 195-207
10. Buller H.R., van Doormaal F.F., van Sluis G.L., and Kamphuisen P.W. Cancer and thrombosis: from molecular mechanisms to clinical presentations. J Thromb Haemost 5 Suppl 1 (2007) 246-254
11. Macaulay I.C., Carr P., Gusnanto A., Ouwehand W.H., Fitzgerald D., and Watkins N.A. Platelet genomics and proteomics in human health and disease. J Clin Invest 115 (2005) 3370-3377
12. Boucharaba A., Serre C.M., Gres S., Saulnier-Blache J.S., Bordet J.C., Guglielmi J., et al. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J Clin Invest 114 (2004) 1714-1725
13. Elzey B.D., Tian J., Jensen R.J., Swanson A.K., Lees J.R., Lentz S.R., et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity 19 (2003) 9-19
14. Yu J., Ustach C., and Kim H.R. Platelet-derived growth factor signaling and human cancer. J Biochem Mol Biol 36 (2003) 49-59
15. Pinedo H.M., Verheul H.M., D'Amato R.J., and Folkman J. Involvement of platelets in tumour angiogenesis?. Lancet 352 (1998) 1775-1777
16. Ibele G.M., Kay N.E., Johnson G.J., and Jacob H.S. Human platelets exert cytotoxic effects on tumor cells. Blood 65 (1985) 1252-1255
17. Ahmad R., Menezes J., Knafo L., and Ahmad A. Activated human platelets express Fas-L and induce apoptosis in Fas-positive tumor cells. J Leukoc Biol 69 (2001) 123-128
18. Heijnen H.F., Schiel A.E., Fijnheer R., Geuze H.J., and Sixma J.J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94 (1999) 3791-3799
19. Nomura S., Inami N., and Iwasaka T. Differences in functional roles between activated platelets and platelet-derived microparticles. Thromb Haemost 98 (2007) 1143-1144
20. Flaumenhaft R. Formation and fate of platelet microparticles. Blood Cells Mol Dis 36 (2006) 182-187
21. Azevedo L.C., Janiszewski M., Pontieri V., Pedro Mde A., Bassi E., Tucci P.J., et al. Platelet-derived exosomes from septic shock patients induce myocardial dysfunction. Crit Care 11 (2007) R120
22. Ardoin S.P., Shanahan J.C., and Pisetsky D.S. The role of microparticles in inflammation and thrombosis. Scand J Immunol 66 (2007) 159-165
23. Sprague D.L., Sowa J.M., Elzey B.D., and Ratliff T.L. The role of platelet CD154 in the modulation in adaptive immunity. Immunol Res 39 (2007) 185-193
24. Weyrich A.S., and Zimmerman G.A. Platelets: signaling cells in the immune continuum. Trends Immunol 25 (2004) 489-495
25. von Hundelshausen P., and Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 100 (2007) 27-40
26. Garcia-Lora A., Algarra I., and Garrido F. MHC class I antigens, immune surveillance, and tumor immune escape. J Cell Physiol 195 (2003) 346-355